Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-16

Clinical Trial Update: A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease

View source ↗

Summary

This completed cross-sectional study from Zhujiang Hospital investigates the association between gut microbiota–derived peptidoglycan fragments and alcohol-asso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zhujiang Hospital | Conditions: Alcohol-associated Liver Disease | Status: COMPLETED